Latest filing published 13 Apr 2012 for Eloxx Pharmaceuticals, Inc..
Insider track record
No signal scores available.
Paul Edward Klaver: trading record in brief
Paul Edward Klaver discloses dealings in Eloxx Pharmaceuticals, Inc. to SEC (Form 4). The record holds 4 filings, for trades running from 15 March 2012 to 22 March 2012.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 13 April 2012 came the latest disclosure, a transaction in Eloxx Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 26 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Paul Edward Klaver
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000,000 shares0Common StockSEC:0001145443-12-000344:0
- 2,000,000 shares0Common StockSEC:0001145443-12-000344:1
- 3,000,000 shares0Common StockSEC:0001145443-12-000344:2
- 3,000,000 shares0Common StockSEC:0001145443-12-000344:3
4 of 4 declarations
